United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - tablet, film coated - 2.5 mg - bisoprolol and hydrochlorothiazide is indicated in the management of hypertension. bisoprolol and hydrochlorothiazide is contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - bisoprolol fumarate 10 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; iron oxide yellow; iron oxide red; macrogol 4000; titanium dioxide; hypromellose; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol fumarate tablets are indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate tablets are contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block and marked sinus bradycardia.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; iron oxide yellow; crospovidone; magnesium stearate; maize starch; iron oxide red; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle medical unlimited company - bisoprolol fumarate - tablet - 10 milligram(s) - beta blocking agents, selective; bisoprolol

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol is indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.

Australia - English - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; iron oxide red; maize starch; microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides